|
TCEB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.3754000000047E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.365000E-04 |
| Normal-vs-Stage2 |
3.558300E-03 |
| Normal-vs-Stage3 |
4.750300E-04 |
| Normal-vs-Stage4 |
2.284000E-03 |
| Stage1-vs-Stage2 |
2.856400E-01 |
| Stage1-vs-Stage3 |
2.706400E-01 |
| Stage1-vs-Stage4 |
7.916600E-01 |
| Stage2-vs-Stage3 |
7.947600E-01 |
| Stage2-vs-Stage4 |
4.008400E-01 |
| Stage3-vs-Stage4 |
4.512600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.837860E-04 |
| Normal-vs-AfricanAmerican |
1.513890E-02 |
| Normal-vs-Asian |
5.897600E-03 |
| Caucasian-vs-AfricanAmerican |
9.295600E-01 |
| Caucasian-vs-Asian |
7.290000E-01 |
| AfricanAmerican-vs-Asian |
8.803800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.157700E-04 |
| Normal-vs-Female |
2.246400E-04 |
| Male-vs-Female |
5.049800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.353600E-04 |
| Normal-vs-Age(41-60Yrs) |
9.388700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.936600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.249220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.361200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.121200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.031600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.565800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.208200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.732000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.758800E-01 |
| Classical-VS-Follicular |
3.761500E-02 |
| Classical-VS-Other |
6.679800E-01 |
| Classical-VS-Normal |
4.339500E-03 |
| Tall-VS-Follicular |
3.883600E-01 |
| Tall-VS-Other |
8.735200E-01 |
| Tall-VS-Normal |
7.217700E-02 |
| Follicular-VS-Other |
7.517400E-01 |
| Follicular-VS-Normal |
5.59860000000079E-05 |
| Other-VS-Normal |
7.918300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.69239999999937E-05 |
| Normal-vs-N1 |
8.972600E-04 |
| N0-vs-N1 |
5.872400E-01 |
|
|
